Prelude Capital Management’s Elanco Animal Health ELAN Stock Holding History

Prelude Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,167	Closed	-$291K	–	1316
2026 Q1	$291K	Buy	+12,167	New	+$297K	0.02%	721
2022 Q4	–	Sell	-17,021	Closed	-$211K	–	1401
2022 Q3	$211K	Buy	+17,021	New	+$298K	0.01%	1057
2021 Q2	–	Sell	-7,210	Closed	-$212K	–	1710
2021 Q1	$212K	Buy	+7,210	New	+$222K	0.01%	1305
2020 Q4	–	Sell	-3,420	Closed	-$96K	–	1459
2020 Q3	$96K	Sell	3,420 -33,142	-91%	-$840K	﹤0.01%	922
2020 Q2	$784K	Buy	36,562 +36,207	+10,199%	+$800K	0.04%	371
2020 Q1	$8K	Buy	+355	New	+$9.72K	﹤0.01%	1160
2018 Q4	–	Sell	-667	Closed	-$23K	–	1869
2018 Q3	$23K	Buy	+667	New	+$23.5K	﹤0.01%	1283

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Prelude Capital Management's ELAN Position: Q2 2026 in Review

Prelude Capital Management sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 12,167 shares — an estimated $291K sold.

Prelude Capital Management first reported a position in ELAN in Q3 2018 and held it in 7 quarters. The position peaked at $784K in Q2 2020. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Prelude Capital Management reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
Prelude Capital Management sold 12,167 Elanco Animal Health shares in Q2 2026, an estimated $291K.
Prelude Capital Management first reported a position in Elanco Animal Health in Q3 2018 and held it in 7 quarters.
Prelude Capital Management's Elanco Animal Health position peaked at $784K in Q2 2020.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.